Wang Yu, Ning Zhong H, Tai Hong W, Long Shuang, Qin Wei C, Su Li M, Zhao Yuan H
State Environmental Protection Key Laboratory of Wetland Ecology and Vegetation Restoration, School of Environment, Northeast Normal University, Changchun, Jilin 130117, PR China.
State Environmental Protection Key Laboratory of Wetland Ecology and Vegetation Restoration, School of Environment, Northeast Normal University, Changchun, Jilin 130117, PR China.
Regul Toxicol Pharmacol. 2015 Mar;71(2):205-12. doi: 10.1016/j.yrtph.2014.12.019. Epub 2014 Dec 31.
The lethal toxicity (LD₅₀) in oral administration, intravenous, intraperitoneal, intramuscular and subcutaneous injections were used to investigate relationships of log 1/LD₅₀ from different exposure routes. Regression analysis showed that log 1/LD₅₀ in oral route was related to the toxicity in injection route. This relationship in lethality between the two routes is apparently due to the same mechanisms of the compounds to the same species. However, the scatter in the correlation curve indicates that exposure route is an important factor that influences the relationship. Some compounds with low intestinal absorption exhibit much less toxicity in oral administration than that in the injection route. A systemic bias of log 1/LD₅₀ between oral and injection routes indicates that tissue distribution of compounds between blood and target site is a very rapid process, leading to log 1/LD₅₀ in injection greater than those in oral administration. Although compounds can be metabolized in the body both from oral and injection routes, first-pass metabolism occurs in oral route but not in injection route. This will result in decrease of toxicity in oral route for most compounds as compared with injection route. In addition, experimental uncertainty, differences in gender, and species can also affect relationships of log1/LD₅₀ between exposure routes.
采用口服、静脉注射、腹腔注射、肌肉注射和皮下注射的致死毒性(LD₅₀)来研究不同暴露途径的log 1/LD₅₀之间的关系。回归分析表明,口服途径的log 1/LD₅₀与注射途径的毒性相关。这两种途径在致死性方面的这种关系显然是由于化合物对同一物种的作用机制相同。然而,相关曲线中的离散表明暴露途径是影响这种关系的一个重要因素。一些肠道吸收低的化合物在口服给药时的毒性远低于注射途径。口服和注射途径之间log 1/LD₅₀的系统性偏差表明化合物在血液和靶部位之间的组织分布是一个非常快速的过程,导致注射途径的log 1/LD₅₀大于口服途径。尽管化合物通过口服和注射途径都能在体内代谢,但首过代谢发生在口服途径而非注射途径。这将导致大多数化合物口服途径的毒性相较于注射途径降低。此外,实验的不确定性、性别差异和物种差异也会影响暴露途径之间log1/LD₅₀的关系。